Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.

[1]  N. Bruining,et al.  Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. , 2006, Journal of the American College of Cardiology.

[2]  N. Weissman,et al.  Pivotal, randomized U.S. study of the Symbiot™ covered stent system in patients with saphenous vein graft disease: Eight‐month angiographic and clinical results from the Symbiot III trial , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[3]  K. Kent,et al.  Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention. , 2006, Journal of interventional cardiology.

[4]  W. Weintraub,et al.  Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era. , 2006, The Journal of invasive cardiology.

[5]  A. Shah,et al.  Drug‐eluting stenting is superior to bare metal stenting in saphenous vein grafts , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  R. Heuser,et al.  Distal embolic protection for SVG interventions: can we afford not to use it? , 2005, Journal of interventional cardiology.

[7]  P. Serruys,et al.  Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents. , 2005, American Journal of Cardiology.

[8]  I. Iakovou,et al.  Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. , 2005, Journal of the American College of Cardiology.

[9]  M. Schalij,et al.  Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: The Venestent Study , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[10]  C. Di Mario,et al.  Randomized Evaluation of Polytetrafluoroethylene‐Covered Stent in Saphenous Vein Grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial , 2003, Circulation.

[11]  G. Stone,et al.  Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting. , 2001, The American journal of cardiology.

[12]  C. White,et al.  Percutaneous intervention of old degenerated saphenous vein grafts , 2001, International journal of cardiovascular interventions.

[13]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[14]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[15]  G. Stone,et al.  Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.

[16]  T. Piemonte,et al.  Angiographic and clinical outcomes following acute infarct angioplasty on saphenous vein grafts. , 1999, The American journal of cardiology.

[17]  M. Leon,et al.  Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. , 1997, The New England journal of medicine.

[18]  W. Weintraub,et al.  Short- and long-term outcome of narrowed saphenous vein bypass graft: a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty. , 1997, American heart journal.

[19]  P. Teirstein,et al.  Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. , 1995, Journal of the American College of Cardiology.

[20]  R A Schatz,et al.  Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aortocoronary saphenous vein grafts. , 1994, The American journal of cardiology.

[21]  M. Bourassa,et al.  Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. , 1985, Circulation.

[22]  Cass Principal Investigators and Their Associates.  Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. , 1984, The New England journal of medicine.

[23]  E. Topol,et al.  Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. , 1997, The American journal of cardiology.